Holen Sie sich die Stockscreener-App
247.26
1.61%
-4.05
Handel nachbörslich:
252.20
4.94
+2.00%
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
9.51%
107.11
|
97.80 | 96.04 | 88.18 | 83.84 |
Operating Expenses
|
11.36%
62.84
|
56.43 | 56.73 | 52.01 | 61.41 |
| Benefits Costs and Expenses |
12.32%
55.97
|
49.83 | 49.27 | 44.59 | 54.07 |
| Costs And Expenses |
12.32%
55.97
|
49.83 | 49.27 | 44.59 | 54.07 |
| Operating Income/Loss |
7.00%
44.27
|
41.37 | 39.31 | 36.18 | 22.43 |
| Income/Loss From Continuing Operations Before Tax |
6.60%
51.13
|
47.97 | 46.77 | 43.60 | 29.77 |
| Income Tax Expense/Benefit |
99.14%
-0.269
|
-31.40 | 8.442 | 7.864 | 2.589 |
| Income/Loss From Continuing Operations After Tax |
35.24%
51.40
|
79.36 | 38.33 | 35.73 | 27.18 |
|
Net Income/Loss
|
35.24%
51.40
|
79.36 | 38.33 | 35.73 | 27.18 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.82%
0.051
|
28.95 | 28.91 | 28.82 | 28.72 |
| Diluted Average Shares |
99.59%
0.122
|
29.83 | 29.75 | 29.87 | 29.90 |
| Basic Earnings Per Share |
35.40%
1.77
|
2.74 | 1.33 | 1.24 | 0.95 |
| Diluted Earnings Per Share |
36.09%
1.70
|
2.66 | 1.29 | 1.20 | 0.91 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):